OncoSec Medical (NSDQ:ONCS) said yesterday that it inked a warrant exercise agreement with unnamed holders of outstanding warrants to buy up to 5.5 million shares of the company’s common stock at an exercise price of $1.69 apiece.
The San Diego, Calif.-based company raised $9.3 million in gross proceeds from the exercise of the warrants, which it plans to use for working capital and general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.
The post OncoSec Medical lands $9.3m in warrant exercise deal appeared first on MassDevice.